KIR2D |
Killer cell immunoglobulin-like receptor |
NK cells |
Specific for HLA-C; inhibitory effect on NK cell |
CD158 and 2DL3 |
|
KIR2DL4 |
Killer cell immunoglobulin-like receptor |
NK cells |
Binds MHC I and activates NK cells |
CD158D, KIR103, 2DL4, and KIR103AS |
|
LIR-1 |
Leukocytes immunoglobulin-like receptor 1 |
Immune cells |
Binds MHC I and inhibits stimulation |
CD85, ILT2, MIR7, LILRB1, and Ig-like receptor 1 |
|
LIR-2 |
Leukocytes immunoglobulin-like receptor 2 |
Immune cells |
Binds MHC I and inhibits stimulation |
CD58D, ILT4, MIR-10, 2 |
|
CD80 |
CD80 molecule |
Macrophages and activated B lymphocytes |
Involved in costimulatory signal for T-lymphocytes activation and works together with CD86 |
CD28LG, CD28LG1, and LAB7 |
|
CD86 |
CD86 molecule |
Antigen presenting cells |
Involved in costimulatory signal for T-lymphocytes activation and works together with CD80 |
CD28LG2, LAB72, B7-2, and B70 |
|
CD9 |
CD9 molecule |
Cells exosomes |
Mediates signal transduction events for regulation of cell development, activation, growth, and motility |
MIC3, BTCC-1, DRAP-27, TSPAN-29, and MRP-1 |